<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37093437</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-7799</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical and experimental nephrology</Title><ISOAbbreviation>Clin Exp Nephrol</ISOAbbreviation></Journal><ArticleTitle>Analysis of the ratio of urinary beta-2-microglobulin to total protein concentration in children with isolated tubulointerstitial disease.</ArticleTitle><Pagination><StartPage>701</StartPage><EndPage>706</EndPage><MedlinePgn>701-706</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10157-023-02349-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Proteinuria is broadly classified into glomerular and tubular proteinuria. Urinary beta-2-microglobulin (&#x3b2;2-MG) is known as a marker for detecting tubulointerstitial diseases. However, tubulointerstitial damage can also lead to an increase in urinary &#x3b2;2-MG level in some patients with glomerular diseases. This study aimed to determine the ratio of urinary &#x3b2;2-MG to total protein (TP) concentration in patients with both isolated tubulointerstitial and glomerular disease.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This multicenter, retrospective study included children with Dent disease or lupus nephritis in five facilities. Their urinary &#x3b2;2-MG levels were&#x2009;&gt;&#x2009;1000&#xa0;&#xb5;g/L. Urinary &#x3b2;2-MG and TP concentrations were obtained, and the ratio of urinary &#x3b2;2-MG to TP concentration (&#xb5;g/mg) was calculated. The Mann-Whitney U test was performed to compare this ratio between these children. The optimal cutoff value of the ratio for considering the presence of glomerular disease was obtained from the receiver operating characteristic (ROC) curve.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We obtained information on 23 children with Dent disease and 14 children with lupus nephritis. The median ratios of urinary &#x3b2;2-MG to TP concentrations in children with Dent disease and lupus nephritis were 84.85 and 1.59, respectively. The ROC curve yielded the optimal cutoff value of this ratio for distinguishing between these diseases, and the cutoff value was found to be 22.3.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In children with tubulointerstitial diseases, the urinary &#x3b2;2-MG concentration may be approximately 8.5% of the TP concentration. The possibility of presenting with glomerular disease should be considered in patients with a ratio of urinary &#x3b2;2-MG to TP concentration of&#x2009;&lt;&#x2009;22.3 (&#xb5;g/mg).</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to The Japanese Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nishimura</LastName><ForeName>Tatsuya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4861-4293</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Aichi Children's Health and Medical Center, 7-426 Morioka-cho, Obu, Aichi, 474-8710, Japan. barcarole_twilight314@yahoo.co.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. barcarole_twilight314@yahoo.co.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uemura</LastName><ForeName>Osamu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Ichinomiya Medical and Habilitation Center, 1679-2 Tomida-nagaresuji, Ichinomiya, Aichi, 494-0018, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hibino</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Aichi Children's Health and Medical Center, 7-426 Morioka-cho, Obu, Aichi, 474-8710, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Kazuki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Aichi Children's Health and Medical Center, 7-426 Morioka-cho, Obu, Aichi, 474-8710, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwata</LastName><ForeName>Naomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Infection and Immunology, Aichi Children's Health and Medical Center, 7-426 Morioka-cho, Obu, Aichi, 474-8710, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Masaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Naka-ku, Hamamatsu, Shizuoka, 430-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsukuma</LastName><ForeName>Eiji</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pediatric Nephrology, Gifu Prefectural General Medical Center, 4-6-1 Noishiki, Gifu, Gifu, 500-8717, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyake</LastName><ForeName>Yoshishige</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Ichinomiya Municipal Hospital, 2-2-22 Bunkyo, Ichinomiya, Aichi, 491-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gotoh</LastName><ForeName>Yoshimitsu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatric Nephrology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, 2-9 Myoken-Cho Showa-ku, Nagoya, Aichi, 466-8650, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujita</LastName><ForeName>Naoya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Aichi Children's Health and Medical Center, 7-426 Morioka-cho, Obu, Aichi, 474-8710, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Clin Exp Nephrol</MedlineTA><NlmUniqueID>9709923</NlmUniqueID><ISSNLinking>1342-1751</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001613">beta 2-Microglobulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057973" MajorTopicYN="Y">Dent Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009395" MajorTopicYN="Y">Nephritis, Interstitial</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011507" MajorTopicYN="N">Proteinuria</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001613" MajorTopicYN="N">beta 2-Microglobulin</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Glomerular disease</Keyword><Keyword MajorTopicYN="N">Ratio</Keyword><Keyword MajorTopicYN="N">Tubulointerstitial disease</Keyword><Keyword MajorTopicYN="N">Urinary beta-2-microglobulin</Keyword><Keyword MajorTopicYN="N">&#x3b2;2-MG</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>11</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37093437</ArticleId><ArticleId IdType="doi">10.1007/s10157-023-02349-7</ArticleId><ArticleId IdType="pii">10.1007/s10157-023-02349-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hogg RJ, Portman RJ, Milliner D, et al. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the national kidney foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics. 2000;105:1242&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.105.6.1242</ArticleId><ArticleId IdType="pubmed">10835064</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int. 2003;63:809&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.2003.00840.x</ArticleId><ArticleId IdType="pubmed">12631062</ArticleId></ArticleIdList></Reference><Reference><Citation>Regeniter A, Freidank H, Dickenmann M, Boesken WH, Siede WH. Evaluation of proteinuria and GFR to diagnose and classify kidney disease: systematic review and proof of concept. Eur J Intern Med. 2009;20:556&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2009.03.006</ArticleId><ArticleId IdType="pubmed">19782913</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson PA, Evrin PE, Bergg&#xe5;rd I. Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein. J Clin Invest. 1969;48:1189&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI106083</ArticleId><ArticleId IdType="pubmed">4978446</ArticleId><ArticleId IdType="pmc">322340</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomlinson PA. Low molecular weight proteins in children with renal disease. Pediatr Nephrol. 1992;6:565&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00866510</ArticleId><ArticleId IdType="pubmed">1282825</ArticleId></ArticleIdList></Reference><Reference><Citation>Portman RJ, Kissane JM, Robson AM. Use of &#x3b2;<sub>2</sub> microglobulin to diagnose tubulo-interstitial renal lesions in children. Kidney Int. 1986;30:91&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1986.156</ArticleId><ArticleId IdType="pubmed">3528618</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomlinson PA, Dalton RN, Hartley B, Haycock GB, Chantler C. Low molecular weight protein excretion in glomerular disease: a comparative analysis. Pediatr Nephrol. 1997;11:285&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004670050278</ArticleId><ArticleId IdType="pubmed">9203174</ArticleId></ArticleIdList></Reference><Reference><Citation>Baines RJ, Brunskill NJ. Tubular toxicity of proteinuria. Nat Rev Nephrol. 2011;7:177&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2010.174</ArticleId><ArticleId IdType="pubmed">21151210</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibi Y, Uemura O, Nagai T, et al. The ratios of urinary &#x3b2;2-microglobulin and NAG to creatinine vary with age in children. Pediatr Int. 2015;57:79&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.12470</ArticleId><ArticleId IdType="pubmed">25142083</ArticleId></ArticleIdList></Reference><Reference><Citation>Devuyst O, Thakker RV. Dent&#x2019;s disease. Orphanet J Rare Dis. 2010;5:28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-5-28</ArticleId><ArticleId IdType="pubmed">20946626</ArticleId><ArticleId IdType="pmc">2964617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine T, Komoda F, Miura K, et al. Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe/USA: genetic and clinical studies of 86 unrelated patients with low-molecular-weight proteinuria. Nephrol Dial Transplant. 2014;29:376&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gft394</ArticleId><ArticleId IdType="pubmed">24081861</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780251101</ArticleId><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura O, Nagai T, Ishikura K, et al. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol. 2014;18:626&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10157-013-0856-y</ArticleId><ArticleId IdType="pubmed">24013764</ArticleId></ArticleIdList></Reference><Reference><Citation>Weening JJ, D&#x2019;Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65:521&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2004.00443.x</ArticleId><ArticleId IdType="pubmed">14717922</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura O, Nagai T, Ishikura K, et al. Reference glomerular filtration rate levels in Japanese children: using the creatinine and cystatin C based estimated glomerular filtration rate. Clin Exp Nephrol. 2015;19:683&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10157-014-1042-6</ArticleId><ArticleId IdType="pubmed">25326724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikezumi Y, Honda M, Matsuyama T, et al. Establishment of a normal reference value for serum &#x3b2;2 microglobulin in Japanese children: reevaluation of its clinical usefulness. Clin Exp Nephrol. 2013;17:99&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10157-012-0658-7</ArticleId><ArticleId IdType="pubmed">22797889</ArticleId></ArticleIdList></Reference><Reference><Citation>Donadio C, Lucchesi A, Ardini M, Giordani R, Cystatin C. beta 2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine. J Pharm Biomed Anal. 2001;24:835&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0731-7085(00)00550-1</ArticleId><ArticleId IdType="pubmed">11248475</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaldson MD, Chambers RE, Woolridge MW, Whicher JT. Alpha 1-microglobulin, beta 2-microglobulin and retinol binding protein in childhood febrile illness and renal disease. Pediatr Nephrol. 1990;4:314&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00862506</ArticleId><ArticleId IdType="pubmed">1698438</ArticleId></ArticleIdList></Reference><Reference><Citation>Norden AG, Scheinman SJ, Deschodt-Lanckman MM, et al. Tubular proteinuria defined by a study of Dent&#x2019;s (CLCN5 mutation) and other tubular diseases. Kidney Int. 2000;57:240&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.2000.00847.x</ArticleId><ArticleId IdType="pubmed">10620205</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang F, Xiao H, Yao Y. The ratio of urinary &#x3b1;1-microglobulin to microalbumin can be used as a diagnostic criterion for tubuloproteinuria. Intractable Rare Dis Res. 2018;7:46&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/irdr.2017.01079</ArticleId><ArticleId IdType="pubmed">29552446</ArticleId><ArticleId IdType="pmc">5849625</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith ER, Cai MM, McMahon LP, Wright DA, Holt SG. The value of simultaneous measurements of urinary albumin and total protein in proteinuric patients. Nephrol Dial Transplant. 2012;27:1534&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfr708</ArticleId><ArticleId IdType="pubmed">22193048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohisa N, Kanemitsu K, Matsuki R, et al. Evaluation of hematuria using the urinary albumin-to-total-protein ratio to differentiate glomerular and nonglomerular bleeding. Clin Exp Nephrol. 2007;11:61&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10157-006-0451-6</ArticleId><ArticleId IdType="pubmed">17385000</ArticleId></ArticleIdList></Reference><Reference><Citation>Abitbol CL, Chandar J, Onder AM, et al. Profiling proteinuria in pediatric patients. Pediatr Nephrol. 2006;21:995&#x2013;1002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-006-0103-9</ArticleId><ArticleId IdType="pubmed">16773413</ArticleId></ArticleIdList></Reference><Reference><Citation>Lun A, Suslovych M, Drube J, et al. Reliability of different expert systems for profiling proteinuria in children with kidney diseases. Pediatr Nephrol. 2008;23:285&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-007-0661-5</ArticleId><ArticleId IdType="pubmed">18038159</ArticleId></ArticleIdList></Reference><Reference><Citation>Davey PG, Gosling P. Beta 2-microglobulin instability in pathological urine. Clin Chem. 1982;28:1330&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/28.6.1330</ArticleId><ArticleId IdType="pubmed">6176371</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>